<DOC>
	<DOCNO>NCT02209610</DOCNO>
	<brief_summary>A hallmark patient heart failure ( HF ) premature fatigue impairs quality life depict major source morbidity . Premature fatigue may attribute ) contraction-induced transient change within muscle ( i.e . peripheral fatigue ) and/or b ) failure central nervous system 'drive ' / activate locomotor muscle ( i.e . central fatigue ) . Both determinant fatigue lead reduction muscle 's force power generate capacity compromise ability perform whole body activity ( e.g . walk ) . Recent finding health document group III/IV afferent fiber work muscle play critical role development component fatigue . Specifically , group III/IV muscle afferent limit central motor drive ( CMD ) exercise thereby exaggerate development central fatigue . In contrast , muscle afferent optimize muscle O2 delivery precise regulation circulation ventilation exercise thereby attenuate development peripheral fatigue .</brief_summary>
	<brief_title>Premature Fatigue Veterans With Heart Failure : Neuronal Influences</brief_title>
	<detailed_description>Recent finding HF suggest altered effect group III/IV muscle afferent population . Although normal afferent feedback crucial adequate O2 delivery exercise , excessive neural feedback substantial negative consequence . HF patient characterize augmented neural feedback arise overactive muscle afferent . It hypothesize abnormality compromise locomotor muscle O2 delivery patient . Therefore , abnormally elevated muscle afferent feedback HF might exacerbate , compare healthy age- activity match individual ( CTRLs ) , development peripheral ( via limit O2 delivery ) central ( via restrict CMD ) fatigue exercise . Recent advance non-invasive stimulation technique offer genuine opportunity identify site synaptic mechanism mediate central peripheral fatigue include alteration responsiveness corticospinal tract ( i.e . determinant central fatigue ) . Taken together , propose study aim determine impact HF precise development central peripheral fatigue whole body single muscle exercise evaluate extent group III/IV muscle afferent contribute development .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>subject history stable cardiomyopathy ( ischemic nonischemic , &gt; 1yr duration , age 2075 yr ) , pacemaker dependent ( biventricular pacer ) , NYHA class II III symptom , Left ventricular ejection fraction ( LVEF ) &lt; 35 % , minimal smoke history ( &lt; 15 pk yr ) stable medication . The investigator also study subject preserve ejection fraction heart failure preserve ejection fraction ( HFpEF ) ; LVEF &gt; 50 % , &gt; 1yr duration , age 2075 yr , pacemaker dependent , NYHA class II III symptom , minimal smoke history ( &lt; 15 pk yr ) stable medication . The investigator exclude morbidly obese patient ( BMI &gt; 35 ) , patient uncontrolled hypertension ( &gt; 160/100 ) , anemia ( Hgb &lt; 9 ) severe renal insufficiency ( individual creatinine clearance &lt; 30 CockcroftGault formula ) . Patients significant noncardiac comorbidities , present could alter study result , exclude . Patients sedentary , define regular physical activity least prior 6 month current activity level document activity questionnaire . Candidates must orthopedic limitation would prohibit perform exercise . Due typical age patient heart failure , woman postmenopausal ( either natural surgical ) define cessation menses least 2 year , woman without uterus , follicle stimulate hormone ( FSH ) &gt; 40 IU/L . Women currently take hormone replacement therapy ( HRT ) exclude propose study due direct vascular effect HRT . Patients pacemaker / defibrillator exclude study due use magnetic/electric stimulators .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Heart Failure</keyword>
</DOC>